1
Home
Companies

Antibe Therapeutics

Antibe Therapeutics
Leadership team

Daniel Marcel Legault (President, CEO, Secretary & Director)

Walter Minnes MacNee (Independent Vice Chair)

Harvey Schipper (Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Medical, Therapeutics
Number of Employees
0 - 50
Headquarters
Toronto, Ontario, Canada
Established
2010
Traded as
OTCQX:ATBPF
Social Media
URL
antibethera.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Antibe Therapeutics Inc. (“Antibe”) is a publicly traded biopharmaceutical company leading a revolution in the development of safer medicines for pain. Its proprietary technology is designed to reduce the overall risk of gastrointestinal damage associated with the long-term use of commonly prescribed NSAID pain medications by optimizing the potency and selectivity of the active drug molecule. Antibe’s lead drug, ATB-346, is a non-addictive, ibuprofen-based molecule in late-stage premedical development for the treatment of moderate to severe pain.
History

Antibe was founded in 2011 with the mission to revolutionize industry approach to the development of therapeutic products for the benefit of the individuals and society. In June 2020, the company completed the acquisition of Aequus Pharmaceuticals’ pain business, and a licensing and collaboration agreement with Daiichi Sankyo, significantly enhancing its clinical development capabilities and providing additional financial resources.

Mission
Antibe’s mission is to develop safer and more effective medicines, and to ensure access to life-saving treatments for as many people as possible.
Vision
Antibe’s vision is to become a world leader in developing safer and more effective pain medications, and to be recognized as a company that has made a real impact on public health.
Key Team

Richard H. Hunt (Member of Scientific Advisory Board)

Peter B. Ernst (Member of Scientific Advisory Board)

Yung C. Wu (Independent Director)

Jennifer Isacoff McNealey (Independent Director)

Angus C. Russell (Member of Advisory Board)

Angel Lanas (Member of Clinical Advisory Board)

Gilberto de Nucci (Member of Scientific Advisory Board)

Daniel Kalman Podolsky (Member of Scientific Advisory Board)

Philip M. Sherman (Member of Scientific Advisory Board)

Francis Chan (Member of Clinical Advisory Board)

Andrew Kenneth Williams Powell (Member of Advisory Board)

William Sessa (Member of Scientific Advisory Board)

Robert E. Hoffman (Independent Chair of the Board)

Roderick John Flower (Independent Director)

Louis Joseph Ignarro (Member of Scientific Advisory Board)

Dominique P. Monnet (Member of Advisory Board)

J. Carter Thorne (Member of Clinical Advisory Board)

Amal Khouri (Independent Director)

Derek Gilroy (Member of Scientific Advisory Board)

Andre Gerald Buret (Member of Scientific Advisory Board)

James Scheiman (Member of Clinical Advisory Board)

Giuseppe Cirino (Member of Scientific Advisory Board)

Donald D. Haut (Partnering Advisory Team)

John Lawrence Wallace (Founder & Vice Chair)

Recognition and Awards
Antibe has received several awards and recognitions, including the New Frontier Award from the National Institute of Health’s Foundation for Biomedical Innovation, the CMEA Award from the Silicon Valley Technology Council, and the Canadian Innovation Exchange’s Top 20 Award. It has also been recognized by the B�DV Management Group as one of Canada’s Top Ten Emerging Life Sciences Companies.
References

https://in.investing.com/equities/antibe-therapeutics-inc.

https://www.crunchbase.com/organization/antibe-therapeutics

antibethera.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Antibe Therapeutics
Leadership team

Daniel Marcel Legault (President, CEO, Secretary & Director)

Walter Minnes MacNee (Independent Vice Chair)

Harvey Schipper (Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Medical, Therapeutics
Number of Employees
0 - 50
Headquarters
Toronto, Ontario, Canada
Established
2010
Traded as
OTCQX:ATBPF
Social Media
URL
antibethera.com